FDA Approves Besivance to Treat Conjunctivitis

The U.S. Food and Drug Administration (FDA) has granted additional labeling indications for Bausch + Lomb's Besivance (besifloxacin ophthalmic suspension) 0.6 percent eyedrop. It is now indicated to treat bacterial conjunctivitis infections caused by susceptible isolates of Pseudomonas aeruginosa.

Accutane (Roaccutane) Increases Risk of Eye Infection

"Millions of teenagers suffer from acne, and they deal with the embarrassing skin blemishes by taking popular prescription medications such as Accutane or Roaccutane,"  reports Science Daily. "Now, however, research from Tel Aviv University shows that these pills can also cause eye infections such as conjunctivitis (pink eye) or sties." Read more.

New "Molecular Wipe" Drug Found for Pink Eye

 MedicalNewsToday reports that "scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called 'pink eye' - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new 'molecular wipe' that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry." Read more.